Impact of Omega-3 Fatty Acid Supplementation on Memory Functions in Healthy Older Adults.
暂无分享,去创建一个
A. Flöel | U. Grittner | A. Hahn | N. Külzow | A. Witte | J. Schuchardt | Lucia Kerti | A. V. Witte
[1] D. Delis,et al. California Verbal Learning Test--Second Edition , 2016 .
[2] A. Villringer,et al. Components of a Mediterranean diet and their impact on cognitive functions in aging , 2015, Front. Aging Neurosci..
[3] D. Alexander,et al. Docosahexaenoic Acid and Adult Memory: A Systematic Review and Meta-Analysis , 2015, PloS one.
[4] Shankuan Zhu,et al. Effect of n-3 PUFA supplementation on cognitive function throughout the life span from infancy to old age: a systematic review and meta-analysis of randomized controlled trials. , 2014, The American journal of clinical nutrition.
[5] C. Breitenstein,et al. An object location memory paradigm for older adults with and without mild cognitive impairment , 2014, Journal of Neuroscience Methods.
[6] Lucia Kerti,et al. Long-chain omega-3 fatty acids improve brain function and structure in older adults. , 2014, Cerebral cortex.
[7] W. Stonehouse. Does Consumption of LC Omega-3 PUFA Enhance Cognitive Performance in Healthy School-Aged Children and throughout Adulthood? Evidence from Clinical Trials , 2014, Nutrients.
[8] T. Nettelbeck,et al. Cognitive performance in older adults is inversely associated with fish consumption but not erythrocyte membrane n-3 fatty acids. , 2014, The Journal of nutrition.
[9] D. Rujescu,et al. Higher glucose levels associated with lower memory and reduced hippocampal microstructure , 2013, Neurology.
[10] C. D. de Jager,et al. Computerized adaptation of The Placing Test for early detection of both mild cognitive impairment and Alzheimer’s disease , 2013, Journal of clinical and experimental neuropsychology.
[11] M. Lavialle,et al. Omega-3 fatty acids and brain resistance to ageing and stress: Body of evidence and possible mechanisms , 2013, Ageing Research Reviews.
[12] A. Chin,et al. Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month randomised, double-blind, placebo-controlled trial , 2013, Psychopharmacology.
[13] Cai Song,et al. Cognitive enhancement by omega-3 fatty acids from child-hood to old age: Findings from animal and clinical studies , 2013, Neuropharmacology.
[14] K. Radeborg,et al. Effects of supplementation with n-3 polyunsaturated fatty acids on cognitive performance and cardiometabolic risk markers in healthy 51 to 72 years old subjects: a randomized controlled cross-over study , 2012, Nutrition Journal.
[15] S. Knecht,et al. Non-invasive brain stimulation improves object-location learning in the elderly , 2012, Neurobiology of Aging.
[16] Sarah A. Chau,et al. Effects of omega-3 fatty acids on cognitive performance: a meta-analysis , 2012, Neurobiology of Aging.
[17] A. Dangour,et al. Omega 3 fatty acid for the prevention of cognitive decline and dementia , 2012, The Cochrane database of systematic reviews.
[18] L. Downey,et al. The effects of 90-day supplementation with the Omega-3 essential fatty acid docosahexaenoic acid (DHA) on cognitive function and visual acuity in a healthy aging population , 2012, Neurobiology of Aging.
[19] D. Mozaffarian,et al. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. , 2011, Journal of the American College of Cardiology.
[20] T. Nettelbeck,et al. The older people, omega-3, and cognitive health (EPOCH) trial design and methodology: A randomised, double-blind, controlled trial investigating the effect of long-chain omega-3 fatty acids on cognitive ageing and wellbeing in cognitively healthy older adults , 2011, Nutrition journal.
[21] J. Buckley,et al. Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial , 2011, British Journal of Nutrition.
[22] R. Mayeux,et al. Epidemiology of Alzheimer disease , 2011, Nature Reviews Neurology.
[23] Yael Steinhart,et al. The effect of phosphatidylserine-containing omega-3 fatty acids on memory abilities in subjects with subjective memory complaints: a pilot study , 2010, Clinical interventions in aging.
[24] A. Blackwell,et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline , 2010, Alzheimer's & Dementia.
[25] Marcus Richards,et al. Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial. , 2010, The American journal of clinical nutrition.
[26] A. Korczyn,et al. Phosphatidylserine Containing ω–3 Fatty Acids May Improve Memory Abilities in Non-Demented Elderly with Memory Complaints: A Double-Blind Placebo-Controlled Trial , 2010, Dementia and Geriatric Cognitive Disorders.
[27] H. Su. Mechanisms of n-3 fatty acid-mediated development and maintenance of learning memory performance. , 2010, The Journal of nutritional biochemistry.
[28] Libin Cui,et al. Improved spatial learning performance of fat-1 mice is associated with enhanced neurogenesis and neuritogenesis by docosahexaenoic acid , 2009, Proceedings of the National Academy of Sciences.
[29] Vincenzo Paolo Senese,et al. Visuospatial memory in healthy elderly, AD and MCI: a review. , 2009, Current aging science.
[30] R. Kessels,et al. How the brain remembers and forgets where things are: The neurocognition of object–location memory , 2008, Neuroscience & Biobehavioral Reviews.
[31] A. Beekman,et al. Effect of fish oil on cognitive performance in older subjects , 2008, Neurology.
[32] A. Veronica Witte,et al. Lifestyle and Memory in the Elderly , 2008, Neuroepidemiology.
[33] D. Snodderly,et al. Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women , 2008, Nutritional neuroscience.
[34] J. Petrella,et al. Prognostic Value of Posteromedial Cortex Deactivation in Mild Cognitive Impairment , 2007, PLoS ONE.
[35] C. von Schacky,et al. Omega-3 fatty acids and cardiovascular disease , 2007, Current opinion in clinical nutrition and metabolic care.
[36] W. Harris,et al. Cardiovascular benefits of omega-3 fatty acids. , 2007, Cardiovascular research.
[37] O. Shido,et al. Docosahexaenoic acid promotes neurogenesis in vitro and in vivo , 2006, Neuroscience.
[38] Noriyuki Matsukawa,et al. Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction , 2006, Neuroscience Research.
[39] J. Billard. Ageing, hippocampal synaptic activity and magnesium. , 2006, Magnesium research.
[40] L. Arterburn,et al. Distribution, interconversion, and dose response of n-3 fatty acids in humans. , 2006, The American journal of clinical nutrition.
[41] F. Corradeschi,et al. Cognitive and physiological effects of Omega‐3 polyunsaturated fatty acid supplementation in healthy subjects , 2005, European journal of clinical investigation.
[42] J. Morris,et al. Mild cognitive impairment and preclinical Alzheimer's disease. , 2005, Geriatrics.
[43] A. Meyer-Lindenberg,et al. The Brain-derived Neurotrophic Factor Val66met Polymorphism and Variation in Human Cortical Morphology , 2022 .
[44] F. Gomez-Pinilla,et al. Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. , 2004, Journal of neurotrauma.
[45] T. Hara,et al. Improvement of spatial cognition with dietary docosahexaenoic acid is associated with an increase in Fos expression in rat CA1 hippocampus , 2004, Clinical and experimental pharmacology & physiology.
[46] M. Egan,et al. The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function , 2003, Cell.
[47] S. Hossain,et al. Chronic Administration Of Docosahexaenoic Acid Improves The Performance Of Radial Arm Maze Task In Aged Rats , 2001, Clinical and experimental pharmacology & physiology.
[48] N. Nishiyama,et al. Docosahexaenoic acid improves long‐term potentiation attenuated by phospholipase A2 inhibitor in rat hippocampal slices , 2001, British journal of pharmacology.
[49] P Weber,et al. Triglyceride-lowering effect of omega-3 LC-polyunsaturated fatty acids--a review. , 2000, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[50] K. Wesnes,et al. Validity and utility of the cognitive drug research (CDR) computerised cognitive testing system: A review following fifteen years of usage , 1999, European Neuropsychopharmacology.
[51] Romola S. Bucks,et al. Development and validation of the Location Learning Test (LLT): A test of visuo-spatial learning designed for use with older adults and in dementia , 1997 .
[52] D. Watson,et al. Development and validation of brief measures of positive and negative affect: the PANAS scales. , 1988, Journal of personality and social psychology.
[53] S. Folstein,et al. “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .
[54] M. Hashimoto,et al. Neuroprotective and ameliorative actions of polyunsaturated fatty acids against neuronal diseases: beneficial effect of docosahexaenoic acid on cognitive decline in Alzheimer's disease. , 2011, Journal of pharmacological sciences.
[55] D. Ma,et al. Experimental models and mechanisms underlying the protective effects of n-3 polyunsaturated fatty acids in Alzheimer's disease. , 2009, The Journal of nutritional biochemistry.
[56] Morris Moscovitch,et al. Item and associative memory in amnestic mild cognitive impairment: performance on standardized memory tests. , 2008, Neuropsychology.
[57] I. Frey,et al. Freiburger Fragebogen zur körperlichen Aktivität-Entwicklung, Prüfung und Anwendung , 2005, Sozial- und Präventivmedizin.